Xiaomi is looking to expand its horizons. The company has partnered up with Silicon Valley based company, iHealth, to bring some personal health products to the Chinese market without the hefty price tag. This comes after an announcement from Xiaomi Ventures of a USD$ 25 million (RM 81.5 million) investment into iHealth Labs. The Silicon Valley based iHealth Labs is health centric organisation focusing on bringing health centric mobile products for the everyday consumer.
As a result of this investment and partnership, Xiaomi has launched its first ever healthcare product – a sphygmomanometer, more commonly known as the Blood Pressure monitor or cuff. The device has launched exclusively in China on Xiaomi’s official website for ¥199 (RM 106/USD$ 32). This comes way under other iHealth offerings which come courtesy of Apple which cost about ¥799 (RM 425) in China.
Xiaomi touts the new device as a user friendly and also reliable on a professional level meeting all necessary professional medical standards and certifications. The Blood pressure cuff works in conjunction with an application which has been customized for Xiaomi and will be able to track vital stats such as your blood pressure, heart rate and pulse in addition to other statistics on a real-time chart. Using this data, the application will then make recommendations for the user to improve. While Xiaomi may be the organisation announcing the device, a spokesperson for the Chinese Manufacturer has revealed to Tech in Asia that the blood pressure monitor can work with other Android devices but is suited to Xiaomi’s own devices.
Xiaomi joins the ranks of Apple and Samsung in introducing its own customised health centric accessories. Samsung has offered, in limited markets, its S Health related monitors which retail at a premium similar to the iHealth devices designed for Apple.
Source: Tech In Asia